article thumbnail

Owlet Announces FDA-Clearance of the First Prescription Pulse Oximetry Sock for Infants

Legacy MEDSearch

Food and Drug Administration (“FDA”) of BabySat , the first medical pulse-oximetry device featuring its advanced, wire-free sock design. Innovation in the baby care space matters because some of the largest issues facing caregivers and healthcare providers have yet to be solved. BabySat will be available in the U.S.

article thumbnail

HOW TO MAXIMIZE THE IMPACT OF PEER INFLUENCE: Top 3 Tips for Content Creation and Delivery

PM360

Furthermore, a 2023 FDA-backed study found that many HCPs do not accurately interpret clinical trial data presented with certain visual graphics, such as graphs and figures with complex features, and that this uncertainty may impact their prescribing decisions. References: Physician Learning Preferences: A Doximity Report.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Selling to Physicians from a Physician’s Perspective

MedCepts

Therefore, the first thing to consider when selling to physicians is that your product, device or service is safe. In addition, it needs to be approved either by the FDA or other respective authorizing body. Physicians Seek Evidence based information. When selling to physicians, yours answers should preferably be evidence based.

article thumbnail

Healthcare Watch October 2023

PM360

Of the eight FDA-approved weight loss drugs on the market, these two are making waves for doctors who believe they represent “a new era for weight loss medications,” and “changing options and giving hope.” They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP).

article thumbnail

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. million people in the UK and 2.7

article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

article thumbnail

Healthcare Watch November 2022

PM360

After surveying 2,005 nationally representative Americans, PatientPoint found that more than half are too afraid to ask their healthcare provider about their health condition or symptoms, with men even more afraid of these interactions than women (57% vs. 45%). Doctor Docs: Physicians Need Info to Treat Long COVID.